HomeIMMX • NASDAQ
add
Immix Biopharma Inc
Previous close
$9.11
Day range
$8.54 - $9.60
Year range
$1.34 - $11.61
Market cap
456.55M USD
Avg Volume
800.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.89M | 118.43% |
Net income | -10.69M | -122.11% |
Net profit margin | — | — |
Earnings per share | -0.28 | -86.67% |
EBITDA | -10.84M | -118.29% |
Effective tax rate | -0.11% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 100.41M | 467.86% |
Total assets | 104.84M | 356.86% |
Total liabilities | 11.04M | 13.90% |
Total equity | 93.80M | — |
Shares outstanding | 52.96M | — |
Price to book | 5.15 | — |
Return on assets | -43.60% | — |
Return on capital | -52.25% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -10.69M | -122.11% |
Cash from operations | -11.03M | -647.16% |
Cash from investing | -6.65M | -1,210.46% |
Cash from financing | 95.67M | — |
Net change in cash | 77.98M | 3,982.61% |
Free cash flow | -7.24M | -3,384.75% |
About
Founded
2012
Headquarters
Website
Employees
18
